Yoshihiro Uto

4.0k total citations
161 papers, 3.3k citations indexed

About

Yoshihiro Uto is a scholar working on Molecular Biology, Cancer Research and Biomedical Engineering. According to data from OpenAlex, Yoshihiro Uto has authored 161 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Molecular Biology, 36 papers in Cancer Research and 33 papers in Biomedical Engineering. Recurrent topics in Yoshihiro Uto's work include Cancer, Hypoxia, and Metabolism (31 papers), Nanoplatforms for cancer theranostics (24 papers) and Photodynamic Therapy Research Studies (12 papers). Yoshihiro Uto is often cited by papers focused on Cancer, Hypoxia, and Metabolism (31 papers), Nanoplatforms for cancer theranostics (24 papers) and Photodynamic Therapy Research Studies (12 papers). Yoshihiro Uto collaborates with scholars based in Japan, United States and South Korea. Yoshihiro Uto's co-authors include Hitoshi Hori, Hideko Nagasawa, Hiroki Kondo, Shigeori Takenaka, Makoto Takagi, Kenichi Yamashita, Eiji Nakata, Kenneth L. Kirk, Toshihiro Hashimoto and Shigenori Kumazawa and has published in prestigious journals such as SHILAP Revista de lepidopterología, Analytical Chemistry and Applied and Environmental Microbiology.

In The Last Decade

Yoshihiro Uto

158 papers receiving 3.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yoshihiro Uto Japan	31	1.3k	598	513	474	387	161	3.3k
Hitoshi Hori Japan	33	1.9k 1.5×	405 0.7×	508 1.0×	632 1.3×	399 1.0×	218	4.6k
Suk‐Jae Chung South Korea	35	2.0k 1.5×	457 0.8×	151 0.3×	345 0.7×	183 0.5×	151	5.0k
Miguel López‐Lázaro Spain	34	2.8k 2.1×	423 0.7×	94 0.2×	669 1.4×	495 1.3×	98	5.8k
Patrice Morlière France	36	1.3k 1.0×	763 1.3×	104 0.2×	540 1.1×	112 0.3×	141	3.9k
Tomoko Yamaguchi Japan	36	1.8k 1.3×	225 0.4×	92 0.2×	949 2.0×	778 2.0×	156	5.0k
Jie Tang China	25	1.1k 0.8×	320 0.5×	99 0.2×	194 0.4×	139 0.4×	83	2.6k
Anna Rita Cappello Italy	34	1.9k 1.4×	323 0.5×	71 0.1×	272 0.6×	191 0.5×	93	3.6k
Jue‐Liang Hsu Taiwan	29	1.8k 1.4×	229 0.4×	269 0.5×	242 0.5×	210 0.5×	122	2.9k
Vanicha Vichai Thailand	13	1.6k 1.2×	220 0.4×	72 0.1×	696 1.5×	170 0.4×	30	3.4k

Countries citing papers authored by Yoshihiro Uto

Since Specialization

Citations

This map shows the geographic impact of Yoshihiro Uto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshihiro Uto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshihiro Uto more than expected).

Fields of papers citing papers by Yoshihiro Uto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshihiro Uto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshihiro Uto. The network helps show where Yoshihiro Uto may publish in the future.

Co-authorship network of co-authors of Yoshihiro Uto

This figure shows the co-authorship network connecting the top 25 collaborators of Yoshihiro Uto. A scholar is included among the top collaborators of Yoshihiro Uto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshihiro Uto. Yoshihiro Uto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Terashima, Minoru, Takeshi Suzuki, Takahisa Takino, et al.. (2024). Development of UTX-143, a selective sodium-hydrogen exchange subtype 5 inhibitor, using amiloride as a lead compound. Bioorganic & Medicinal Chemistry. 99. 117603–117603. 1 indexed citations

Yamaguchi, Izumi, Yoshifumi Mizobuchi, Takeshi Miyamoto, et al.. (2023). Differences in amyloid-β and tau/p-tau deposition in blood-injected mouse brains using micro-syringe to mimic traumatic brain microhemorrhages. Journal of Chemical Neuroanatomy. 130. 102258–102258. 1 indexed citations

Terashima, Minoru, et al.. (2021). TGF-β1 facilitates MT1-MMP-mediated proMMP-9 activation and invasion in oral squamous cell carcinoma cells. Biochemistry and Biophysics Reports. 27. 101072–101072. 13 indexed citations

Sootome, Hiroshi, Akihiro Miura, Norio Masuko, et al.. (2020). Aurora A Inhibitor TAS-119 Enhances Antitumor Efficacy of Taxanes In Vitro and In Vivo : Preclinical Studies as Guidance for Clinical Development and Trial Design. Molecular Cancer Therapeutics. 19(10). 1981–1991. 8 indexed citations

Ohta, Toshiro, et al.. (2020). Antiangiogenic Activity of Flavonols in Chorioallantoic Membrane (CAM) Assay. Food Science and Technology Research. 26(6). 891–896. 2 indexed citations

Ohkura, Kazuto, Atsushi Tabata, Yoshihiro Uto, & Hitoshi Hori. (2020). Effect of Isomerization of TX-2036 Derivatives on the Interaction With Tyrosine Kinase Domain of EGF Receptor. Anticancer Research. 40(8). 4675–4680. 1 indexed citations

Hamamura, Kazunori, Andy Chen, Yoshihiro Uto, & Hiroki Yokota. (2015). Potential therapeutic applications of salubrinal for skeletal diseases and beyond. 1(8). 151. 3 indexed citations

Nakanishi, Ikuo, Kei Ohkubo, Yoshihiro Uto, et al.. (2013). Disproportionation of a 2,2-diphenyl-1-picrylhydrazyl radical as a model of reactive oxygen species catalysed by Lewis and/or Brønsted acids. Chemical Communications. 50(7). 814–816. 13 indexed citations

Ikeda, Atsushi, Jun‐ichi Kikuchi, Motofusa Akiyama, et al.. (2011). Formation and regulation of fullerene-incorporation in liposomes under the phase transition temperature. Organic & Biomolecular Chemistry. 9(8). 2622–2622. 25 indexed citations

10.

Nakata, Eiji, Yoshihiro Uto, Hiroshi Maezawa, et al.. (2010). A newly designed cell-permeable SNARF derivative as an effective intracellular pH indicator. Chemical Communications. 46(20). 3526–3526. 51 indexed citations

11.

Nonaka, Koichi, Shinya Onizuka, Hiromi Ishibashi, et al.. (2010). Vitamin D Binding Protein-Macrophage Activating Factor Inhibits HCC in SCID Mice. Journal of Surgical Research. 172(1). 116–122. 30 indexed citations

12.

Uto, Yoshihiro, Eiji Nakata, Hideko Nagasawa, et al.. (2009). Design of Novel Hypoxia-Targeting IDO Hybrid Inhibitors Conjugated with an Unsubstituted L-TRP as an IDO Affinity Moiety. Advances in experimental medicine and biology. 662. 415–421. 5 indexed citations

13.

Paulino, Niraldo, Yoshihiro Uto, Daisuke Koyama, et al.. (2008). Anti-inflammatory effects of a bioavailable compound, Artepillin C, in Brazilian propolis. European Journal of Pharmacology. 587(1-3). 296–301. 238 indexed citations

14.

Masunaga, Shin‐ichiro, Koji Ono, Akihisa Takahashi, et al.. (2003). Usefulness of combined treatment with mild temperature hyperthermia and/or tirapazamine in the treatment of solid tumors: its independence of p53 status. Cancer Science. 94(1). 125–133. 9 indexed citations

15.

Mohamad, Saharuddin Bin, Hitoshi Hori, Hideko Nagasawa, Kenji Usui, & Yoshihiro Uto. (2003). Characterization of Human Gc Protein- Derived Macrophage Activation Factor (GcMAF) and Its Functional Role in Macrophage Tumoricidal Activity. Advances in experimental medicine and biology. 510. 77–82. 11 indexed citations

16.

Hori, Hitoshi, Hideko Nagasawa, Yoshihiro Uto, et al.. (2002). TX-1123: an antitumor 2-hydroxyarylidene-4-cyclopentene-1,3-dione as a protein tyrosine kinase inhibitor having low mitochondrial toxicity. Bioorganic & Medicinal Chemistry. 10(10). 3257–3265. 53 indexed citations

17.

Kasai, Soko, Hideko Nagasawa, Yoshihiro Uto, et al.. (2001). New antimetastatic hypoxic cell radiosensitizers: design, synthesis, and biological activities of 2-nitroimidazole-acetamide, TX-1877, and its analogues. Bioorganic & Medicinal Chemistry. 9(2). 453–464. 41 indexed citations

18.

Masunaga, Shin‐ichiro, Koji Ono, Minoru Suzuki, et al.. (2000). Changes in the Sensitivity of Intratumor Cells during Fractionated Tirapazamine Administration. Japanese Journal of Cancer Research. 91(7). 731–736. 5 indexed citations

19.

Masunaga, Shin‐ichiro, Koji Ono, Minoru Suzuki, et al.. (2000). Usefulness of Tirapazamine as a Combined Agent in Chemoradiation and Thermo‐chemoradiation Therapy at Mild Temperatures: Reference to the Effect on Intratumor Quiescent Cells. Japanese Journal of Cancer Research. 91(5). 566–572. 8 indexed citations

20.

Hori, Hitoshi, Saharuddin Bin Mohamad, Hideko Nagasawa, et al.. (1999). Enhancement Effect of Methyl α-D-Glucoside for Inhibitory Effects of Antioxidants on ADP/Fe2+-Induced Lipid Peroxidation in Rat Liver Mitochondria. Advances in experimental medicine and biology. 471. 395–401. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact